Scott J. Rodig

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

Stephen M. Ansell, Alexander M. Lesokhin, Ivan Borrello et al. · New England Journal of Medicine · 2014 · 3.5K citations · Full text

Medicine, Oncology, Pharmacology +17

An immunogenic personal neoantigen vaccine for patients with melanoma

Patrick A. Ott, Zhuting Hu, Derin B. Keskin et al. · Nature · 2017 · 2.9K citations

Medicine, Immunology, Oncology +12

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

Bo Li, Eric A. Severson, Jean‐Christophe Pignon et al. · Genome biology · 2016 · 2.8K citations · Full text

Life Sciences, Immunology, Oncology +17

Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

Brian C. Miller, Debattama R. Sen, Rose Al Abosy et al. · Nature Immunology · 2019 · 2.1K citations · Full text

Life Sciences, Immunology, Oncology +14

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Bjoern Chapuy, Chip Stewart, Andrew Dunford et al. · Nature Medicine · 2018 · 2K citations · Full text

Medicine, Hematology, Oncology +12